Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 7 chart positions in 7 markets.
By chart position
- 🇺🇸US · Life Sciences#1465K to 30K
- 🇰🇷KR · Life Sciences#7610K to 30K
- 🇸🇪SE · Life Sciences#1551K to 10K
- 🇮🇳IN · Life Sciences#1771K to 10K
- 🇨🇿CZ · Life Sciences#1230K to 100K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
24K to 93K🎙 ~2x weekly·7 episodes·Last published 3w ago - Monthly Reach
Unique listeners across all episodes (30 days)
48K to 186K🇨🇿54%🇺🇸16%🇰🇷16%+4 more - Active Followers
Loyal subscribers who consistently listen
19K to 74K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Episode: 9 - Jack Scarcelli on Moving Beyond One Host, One Vector, One Process for Today’s Cell Line Development
Jun 2, 2026
22m 22s
Episode: 8 - Jack Prior of Sanofi on AI Readiness in Biomanufacturing
May 5, 2026
39m 51s
Episode: 7 - Anurag Rathore on Platform Processes, Chromatography, and Expanding Education
Apr 8, 2026
32m 06s
Episode: 6 - Fireside Chat: Innovation and Investment in Biomanufacturing of Future Medicine
Mar 10, 2026
55m 14s
Episode: 5 - Andrew Sinclair Offers Insight on Optimizing Manufacturing and Operations, Part 2
Feb 3, 2026
35m 14s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | |
|---|---|---|---|---|
| 6/2/26 |  Episode: 9 - Jack Scarcelli on Moving Beyond One Host, One Vector, One Process for Today’s Cell Line Development | In this episode of Bioprocessing Unfiltered, Jack Scarcelli, senior director and head of cell line development at Sanofi, speaks with host Hussain Dahodwala, professor of upstream process development at University of Maryland’s Institute of Bioscience and Biotechnology Research, to discuss technical and strategic challenges in the next gen cell line development in the biopharmaceutical industry. Scarcelli traces his career journey, shares lessons learned over a successful career, and offers t... | 22m 22s | |
| 5/5/26 |  Episode: 8 - Jack Prior of Sanofi on AI Readiness in Biomanufacturing | In this episode of Bioprocessing Unfiltered, Jack Prior, head of process monitoring and data science and AI strategy at Sanofi, explores how AI has evolved from early expert systems to machine learning, generative AI, and agentic AI, and what that means for biomanufacturing today. He explains why digital transformation has not automatically created usable data, and why the real challenge is turning fragmented information from manufacturing systems into accessible, authentic, and analysis-read... | 39m 51s | |
| 4/8/26 |  Episode: 7 - Anurag Rathore on Platform Processes, Chromatography, and Expanding Education | Anurag Rathore, professor of chemical engineering at the Indian Institute of Technology Delhi, joins Bioprocessing Unfiltered with host Alois Jungbauer to discuss his long career in advancing bioprocessing engineering. Rathore shares his thoughts on chromatography, using platform processes to accelerate process development, how infinity capture can be a way to arrive at platform processes, and if there is a need for alternative methods. He also explores updates needed to the traditional curri... | 32m 06s | |
| 3/10/26 |  Episode: 6 - Fireside Chat: Innovation and Investment in Biomanufacturing of Future Medicine | At the most recent Bioprocessing Summit, David Y. H. Chang, CEO of Taiwan Bio-Manufacturing Company; Bo Wiinberg, Chief Business Development Officer of Novo Nordisk Foundation Cellerator; and Paul Lewus, Vice President of Site Operations at Amgen gathered for a fireside chat moderated by Ran Zheng, former CEO of Landmark Bio, to discuss the technologies and innovations shaping the future of biomanufacturing. The conversation explored upcoming trends, investment opportunities, and modalities i... | 55m 14s | |
| 2/3/26 |  Episode: 5 - Andrew Sinclair Offers Insight on Optimizing Manufacturing and Operations, Part 2 | Picking up from their previous conversation on Bioprocessing Unfiltered, Andrew Sinclair, president and founder of BioPharm Services Ltd., and host William Whitford, founder of Oamaru BioSystems, discuss improving manufacturing efficiency, including process mass intensity and setting up parameters, and more on Sinclair’s long career and valuable experiences in the industry. Sinclair also shares advice on helping someone who cannot meet parameters, how to navigate new profusions, and default v... | 35m 14s | |
| 1/6/26 |  Episode: 4 - Andrew Sinclair Offers Insight on Optimizing Manufacturing and Operations - Part 1 | How can we optimize manufacturing and operations? In this episode of Bioprocessing Unfiltered, Andrew Sinclair, president and founder of Biopharm Services, provides insight from his 35-year-long career in the industry on the most significant ways data management and predictive modeling can improve efficiency during the manufacturing process. With host William Whitford, founder of Oamaru BioSystems, Sinclair delves into the history and impact of costs, how to handle evolving efficiencies, and ... | 23m 24s | |
| 12/2/25 |  Episode: 3 - The Future of Gene Therapies and CDMOs with Philip Ramsey | What is the future of gene therapies? In this episode of Bioprocessing Unfiltered, host Susan D’Costa, chief technical and commercial officer of Genezen, and Phillip Ramsey, CTO of Sangamo Therapeutics, discuss a variety of topics about gene therapies, including what will transform viral vector gene therapy, the evolving role of contract development and manufacturing organizations (CDMOs), and how gene editing in general fits into the broader gene therapy landscape. Plus, they cover the three... | 34m 42s | |
| 11/4/25 |  Episode: 2 - Georges Belfort Discusses Breakthroughs in mRNA Purification | What makes mRNA purification different from other bioprocessing methods? In this episode of Bioprocessing Unfiltered, host Alois Jungbauer, professor and head of biotechnology at the Institute of Bioprocess Science and Engineering at BOKU University, speaks with Georges Belfort, institute professor of chemical and biological engineering at Rensselaer Polytechnic Institute about his research in mRNA purification and his long, illustrious career in the industry, including the impact of his disc... | 32m 53s | |
| 10/3/25 |  Episode: 1 - Bo Wiinberg on Bridging Research and Trials with Cell-Based Therapies | Are cell therapies the key to bridging the gap between discovery research and clinical trials? In the inaugural episode of the Bioprocessing Unfiltered podcast, Bo Wiinberg, chief business development officer at Novo Nordisk Foundation Cellerator, sat with Ran Zheng, CEO of Landmark Bio and shared his expert insight on the promise cell therapies hold for diseases with only treatments but no cures. Their conversation covers the challenges of navigating cell therapy programs through pre-clinica... | 22m 02s |
Showing 9 of 9
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
8 placements across 7 markets.
Chart Positions
8 placements across 7 markets.